PP_1170x120_10-25-21

BravoVax

GeoVax and BravoVax to team on development of coronavirus vaccine

GeoVax and BravoVax to team on development of coronavirus vaccine

ATLANTA — GeoVax Labs, a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, together with BravoVax, a vaccine developer in Wuhan, China, announced on  Monday the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as 2019-nCoV). Under the collaboration, GeoVax will use its